apomorphine has been researched along with Chronic Disease in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (69.23) | 18.7374 |
1990's | 4 (15.38) | 18.2507 |
2000's | 1 (3.85) | 29.6817 |
2010's | 3 (11.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnett, DG; Ciucci, M; Doll, EJ; Grant, LM; Leverson, G | 1 |
Farhan, M; Haleem, DJ; Ikram, H; Kanwal, S | 1 |
Cantrup, R; Rajakumar, N; Rushlow, WJ; Sathanantham, K | 1 |
Coffeen, U; del Angel, R; López-Avila, A; López-Muñoz, FJ; Ortega-Legaspi, JM; Pellicer, F | 1 |
Ackenheil, M; Albus, M; May, G; Müller-Spahn, F; Naber, D; Welter, D; Zander, K | 1 |
Crow, TJ; Ferrier, IN; Johnstone, EC | 2 |
Bigelow, LB; Cutler, NR; Jeste, DV; Kleinman, JE; Rogol, A; Weinberger, DR; Wyatt, RJ; Zalcman, S | 1 |
Busch, D; Fang, VS; Meltzer, HY | 1 |
Kaplan, JM; Södersten, P | 1 |
Brambilla, F; Fassone, G; Marini, S; Nerozzi, D; Pancheri, P; Picardi, A; Saito, A | 1 |
Davis, JM; Smith, RC; Tamminga, C | 1 |
Davis, JM; Schaffer, MH; Smith, RC; Tamminga, CA | 1 |
Brambilla, F; Guastalla, A; Maffei, C; Nobile, P; Ponzano, M; Rovere, C; Scarone, S | 1 |
Angrist, B; Clark, C; Gershon, S; Halpers, FS; Rotrosen, J; Sachar, EJ | 1 |
Ali, SI; Davis, JM; Ericksen, S; Garver, DL; Pandey, GN; Tamminga, C | 1 |
Davis, JM; Frohman, LA; Pandey, G; Smith, RC; Tamminga, CA | 1 |
Argent, NB; Baylis, PH; Pearce, SH | 1 |
Cabib, S; Puglisi-Allegra, S | 1 |
Davidson, M; Davis, BM; Davis, KL; Losonczy, MF; Mathé, AA; Mohs, RC; Song, IS | 1 |
Bowden, CL; Contreras, SA; Maas, JW; Seleshi, E | 1 |
Cabib, S; Kempf, E; Mele, A; Puglisi-Allegra, S; Schleef, C | 1 |
Ang, VT; Jenkins, JS; Nussey, SS | 1 |
Cotzias, GC | 1 |
Matveev, VF; Vorob'ev, VS | 1 |
1 review(s) available for apomorphine and Chronic Disease
Article | Year |
---|---|
Effect of apomorphine on schizophrenic symptoms.
Topics: Apomorphine; Chronic Disease; Humans; Schizophrenia | 1977 |
5 trial(s) available for apomorphine and Chronic Disease
Article | Year |
---|---|
Clinical effects of apomorphine in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety; Apomorphine; Blinking; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Schizophrenia | 1984 |
Noradrenergic and dopaminergic interrelation in schizophrenia.
Topics: Adolescent; Adult; Apomorphine; Arousal; Chronic Disease; Clonidine; Dopamine; Growth Hormone; Humans; Male; Norepinephrine; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Schizophrenic symptoms improve with apomorphine.
Topics: Apomorphine; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nerve Endings; Receptors, Dopamine; Schizophrenia | 1978 |
Catecholaminergic drugs in chronic schizophrenia.
Topics: Adult; Apomorphine; Carbidopa; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrazines; Imipramine; Levodopa; Luteinizing Hormone; Male; Middle Aged; Placebos; Schizophrenia, Disorganized; Testosterone | 1979 |
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; Dopamine; Double-Blind Method; Female; Haloperidol; Homovanillic Acid; Humans; Loxapine; Male; Random Allocation; Schizophrenia | 1988 |
20 other study(ies) available for apomorphine and Chronic Disease
Article | Year |
---|---|
Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.
Topics: Acute Disease; Animals; Apomorphine; Chronic Disease; Corpus Striatum; Dopamine; Dopamine Agonists; Forelimb; Functional Laterality; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinsonian Disorders; Random Allocation; Rats, Long-Evans; Severity of Illness Index; Tyrosine 3-Monooxygenase; Ultrasonics; Vocalization, Animal | 2015 |
Apomorphine induced conditioned place preference and sensitization is greater in rats exposed to unpredictable chronic mild stress.
Topics: Animals; Apomorphine; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Chronic Disease; Conditioning, Psychological; Disease Models, Animal; Male; Motor Activity; Rats, Wistar; Reinforcement, Psychology; Stress, Psychological | 2015 |
Chronic hyperdopaminergic activity of schizophrenia is associated with increased ΔFosB levels and cdk-5 signaling in the nucleus accumbens.
Topics: Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Blotting, Western; Chronic Disease; Cyclin-Dependent Kinase 5; Dopamine; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Hyperkinesis; Immunohistochemistry; Motor Activity; Nucleus Accumbens; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Schizophrenia; Stress, Psychological; Tissue Fixation | 2012 |
Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Afferent Pathways; Animals; Apomorphine; Benzazepines; Cerebral Cortex; Chronic Disease; Dopamine; Dopamine Agonists; Dopamine Antagonists; Hot Temperature; Male; Microinjections; Models, Neurological; Neuralgia; Nociceptors; Pain; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Sciatic Neuropathy; Self Mutilation; Spiperone | 2008 |
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prolactin; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Time Factors | 1984 |
Cholecystokinin (CCK): ascension from gut to brain.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Bucladesine; Ceruletide; Cholecystokinin; Chronic Disease; Dopamine; Humans; Rats; Rats, Inbred Strains; Schizophrenia; Species Specificity | 1983 |
Apomorphine response and subtyping of schizophrenia.
Topics: Adult; Apomorphine; Cerebral Ventricles; Chronic Disease; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1983 |
Hormonal effects of apomorphine in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Apomorphine; Chronic Disease; Estradiol; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormones, Anterior; Prolactin; Schizophrenia | 1984 |
Hormones, dopamine receptors and schizophrenia.
Topics: Acute Disease; Apomorphine; Chronic Disease; Dopamine; Dopamine Antagonists; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Prolactin; Receptors, Dopamine; Reference Values; Schizophrenia | 1981 |
Apomorphine suppresses ingestive behaviour in chronic decerebrate rats.
Topics: Animals; Apomorphine; Brain Stem; Chronic Disease; Decerebrate State; Depression, Chemical; Feeding Behavior; Male; Rats; Rats, Wistar; Sincalide | 1994 |
Suppression of prolactin by dopamine agonists in schizophrenics and controls.
Topics: Adult; Apomorphine; Chronic Disease; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Schizophrenia | 1978 |
Postsynaptic supersensitivity in schizophrenia.
Topics: Acute Disease; Adenylyl Cyclases; Adolescent; Adult; Apomorphine; Blood Platelets; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prostaglandins E; Receptors, Dopamine; Schizophrenia | 1977 |
A neuroendocrine study of supersensitivity in tardive dyskinesia.
Topics: Adult; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1977 |
Chronic hypernatremia due to impaired osmoregulated thirst and vasopressin secretion.
Topics: Adult; Apomorphine; Arginine Vasopressin; Blood Pressure; Chronic Disease; Drinking; Emetics; Glucose; Humans; Male; Saline Solution, Hypertonic; Sodium; Thirst; Trimethaphan; Water-Electrolyte Balance | 1991 |
Genotype-dependent effects of chronic stress on apomorphine-induced alterations of striatal and mesolimbic dopamine metabolism.
Topics: Animals; Apomorphine; Behavior, Animal; Chronic Disease; Corpus Striatum; Dopamine; Genotype; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Stress, Physiological | 1991 |
Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
Topics: Adult; Apomorphine; Brain; Cerebral Ventricles; Chronic Disease; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Schizophrenia; Secretory Rate | 1986 |
Different effects of acute and chronic stress on two dopamine-mediated behaviors in the mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Animals; Apomorphine; Brain; Caudate Nucleus; Chronic Disease; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nucleus Accumbens; Putamen; Reference Values; Restraint, Physical; Stress, Psychological | 1988 |
Chronic hypernatraemia and hypothermia following subarachnoid haemorrhage.
Topics: Adult; Apomorphine; Arginine Vasopressin; Chromatography, High Pressure Liquid; Chronic Disease; Humans; Hypernatremia; Hypothermia; Male; Osmolar Concentration; Subarachnoid Hemorrhage | 1986 |
Levodopa, manganese, and degenerations of the brain.
Topics: Administration, Oral; Animals; Apomorphine; Blood Urea Nitrogen; Brain Diseases; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chronic Disease; Dietary Proteins; Dopamine; Drug Therapy, Combination; Growth Hormone; Humans; Injections; Levodopa; Manganese Poisoning; Movement Disorders; Neutron Activation Analysis; Parkinson Disease; Psychoses, Substance-Induced; Radioisotopes | 1974 |
[Experience with treatment of chronic alcoholism patients with large doses of metronidazole in psychoneurologic dispensaries].
Topics: Adult; Alcoholism; Apomorphine; Chronic Disease; Fatigue; Feeding and Eating Disorders; Humans; Male; Metronidazole; Middle Aged | 1969 |